Fosun Pharma: Repurchased 1.455 million H shares on September 14.

Fosun Pharma announced that on September 14, 2026, the company repurchased 14.55 million H shares on the Hong Kong Stock Exchange, representing 0.27% of the issued shares prior to the repurchase, at a price range of HK$16.30 to HK$17.14 per share, for a total repurchase amount of HK$24.7051 million. The repurchased shares are intended to be held as treasury shares. This repurchase was made pursuant to the repurchase mandate approved by the shareholders' general meeting on June 16, 2026, under which the total number of shares that may be repurchased is 54.0972 million shares. To date, a cumulative total of 4.859 million shares have been repurchased, representing 0.9% of the issued shares on the date of the mandate. Following this repurchase, there is a 30-day moratorium on new share issuance and the sale/transfer of treasury shares, until October 14, 2026.